KENDRA PROCTOR: Open Payments
NPI 1396764981 · PARIS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,494 in 79 payments from 17 companies in 2025. Trend: 2023 $1,654 · 2024 $1,799 · 2025 $1,494
Food & beverage: $1,494
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $394 |
| GlaxoSmithKline, LLC. | 17 | $289 |
| Lilly USA, LLC | 17 | $209 |
| Novo Nordisk Inc | 10 | $147 |
| PFIZER INC. | 5 | $91 |
| Phathom Pharmaceuticals, Inc. | 6 | $91 |
| Corcept Therapeutics | 4 | $88 |
| ABBVIE INC. | 2 | $32 |
| Insulet Corporation | 1 | $20 |
| SANOFI-AVENTIS U.S. LLC | 1 | $20 |
Products named: AIRSUPRA, TRELEGY ELLIPTA, MOUNJARO, FARXIGA, VOQUEZNA, Korlym, Ozempic, Rybelsus.
Industry payments across TX — which companies pay providers there.
